Regulatory role of miRNA‑26a in neonatal sepsis

Cheng,Qi; Tang,Lili; Wang,Yibiao

doi:10.3892/etm.2018.6779

Regulatory role of miRNA‑26a in neonatal sepsis

Authors:
- Qi Cheng
- Lili Tang
- Yibiao Wang
View Affiliations

Affiliations: Department of Pediatrics, The Second Hospital of Shandong University, Jinan, Shandong 250033, P.R. China, Department of Pediatrics, Gaotang County People's Hospital, Liaocheng, Shandong 252800, P.R. China, Department of Pediatrics, The Second Hospital of Shandong University, Jinan, Shandong 250000, P.R. China
Published online on: September 19, 2018 https://doi.org/10.3892/etm.2018.6779
Pages: 4836-4842

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the expression of microRNA (miRNA) 26a in blood mononuclear cells and serum in neonatal sepsis, as well as its role in the disease pathogenesis. In total 28 cases of neonatal sepsis were included in the study. The mRNA expression levels of miRNA‑26a and interleukin (IL)‑6 in the blood mononuclear cells and serum samples were detected by reverse transcription‑quantitative polymerase chain reaction. The protein expression of IL‑6 was detected by western blot analysis and ELISA. The in vitro septic environment was simulated by lipopolysaccharide (LPS) in THP‑1 cells, and the expression of miRNA‑26a and IL‑6 were determined. Interaction between miRNA‑26a and IL‑6 was confirmed by a dual‑luciferase reporter assay. Compared with the control group, the mRNA and protein expression levels of IL‑6 in the blood mononuclear cells and serum samples from the neonates with sepsis were significantly elevated, while the expression of miRNA‑26a was significantly decreased. In addition, similar results were observed in the LPS‑induced septic models in THP‑1 cells. Furthermore, the results of the dual‑luciferase reporter assay demonstrated that IL‑6 was the direct target of miRNA‑26a. The expression of IL‑6 was significantly upregulated in the blood mononuclear cells and serum in neonatal sepsis, which may be associated with the downregulation of miRNA‑26a. miRNA‑26a may regulate the disease pathogenesis and immune responses.

View Figures

View References

1	Satar M and Ozlü F: Neonatal sepsis: A continuing disease burden. Turk J Pediatr. 54:449–457. 2012.PubMed/NCBI
2	Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, Rudan I, Campbell H, Cibulskis R, Li M, et al: Global, regional and national causes of child mortality: An updated systematic analysis for 2010 with time trends since. Lancet. 379:2151–2161. 2012. View Article : Google Scholar : PubMed/NCBI
3	Raymond SL, Stortz JA, Mira JC, Larson SD, Wynn JL and Moldawer LL: Immunological defects in neonatal sepsis and potential therapeutic approaches. Front Pediatr. 5:142017. View Article : Google Scholar : PubMed/NCBI
4	Wu YQ, Shen J, Zhou QL, Zhao HW, Liu LR and Liu X: Interleukin-6 and interleukin-8 in diagnosing neonatal septicemia. J Biol Regul Homeost Agents. 30:1107–1113. 2016.PubMed/NCBI
5	Delanghe JR and Speeckaert MM: Translational research and biomarkers in neonatal sepsis. Clin Chim Acta. 451:46–64. 2015. View Article : Google Scholar : PubMed/NCBI
6	Anderson AE, Pratt AG, Sedhom MA, Doran JP, Routledge C, Hargreaves B, Brown PM, Cao Lê KA, Isaacs JD and Thomas R: IL-6-driven STAT signalling in circulating CD4+ lymphocytes is a marker for early anticitrullinated peptide antibody-negative rheumatoid arthritis. Ann Rheum Dis. 75:466–473. 2016. View Article : Google Scholar : PubMed/NCBI
7	Tezono K, Sarker KP, Kikuchi H, Nasu M, Kitajima I and Maruyama I: Bioactivity of the vascular endothelial growth factor trapped in fibrin clots: Production of IL-6 and IL-8 in monocytes by fibrin clots. Haemostasis. 31:71–79. 2001.PubMed/NCBI
8	Vila N, Reverter JC, Yague J and Chamorro A: Interaction between interleukin-6 and the natural anticoagulant system in acute stroke. J Interferon Cytokine Res. 20:325–329. 2000. View Article : Google Scholar : PubMed/NCBI
9	Celik HT, Portakal O, Yigit S, Hascelik G, Korkmaz A and Yurdakok M: Efficacy of new leukocyte parameters versus serum C-reactive protein, procalcitonin and interleukin-6 in the diagnosis of neonatal sepsis. Pediatr Int. 58:119–125. 2016. View Article : Google Scholar : PubMed/NCBI
10	Steinberger E, Hofer N and Resch B: Cord blood procalcitonin and Interleukin-6 are highly sensitive and specific in the prediction of early-onset sepsis in preterm infants. Scand J Clin Lab Invest. 74:432–436. 2014. View Article : Google Scholar : PubMed/NCBI
11	Xu Z, Xiao SB, Xu P, Xie Q, Cao L, Wang D, Luo R, Zhong Y, Chen HC and Fang LR: miR-365, a novel negative regulator of interleukin-6 gene expression, is cooperatively regulated by Sp1 and NF-kappaB. J Biol Chem. 286:21401–21412. 2011. View Article : Google Scholar : PubMed/NCBI
12	Subspecialty Group of Neonatology Pediatric Society Chinese Medical Association, . Editorial Board Chinese Journal of Pediatrics. Protocol for diagnosis and treatment of neonatal septicemia. Zhonghua Er Ke Za Zhi. 41:897–899. 2003.(In Chinese). PubMed/NCBI
13	Qazi SA and Stoll BJ: Neonatal sepsis: A major global public health challenge. Pediatr Infect Dis J. 28 1 Suppl:S1–S2. 2009. View Article : Google Scholar : PubMed/NCBI
14	Zhou M, Cheng S, Yu J and Lu Q: Interleukin-8 for diagnosis of neonatal sepsis: A meta-analysis. PLoS One. 10:e01271702015. View Article : Google Scholar : PubMed/NCBI
15	Tunc T, Cekmez F, Cetinkaya M, Kalayci T, Fidanci K, Saldir M, Babacan O, Sari E, Erdem G, Cayci T, et al: Diagnostic value of elevated CXCR4 and CXCL12 in neonatal sepsis. J Matern Fetal Neonatal Med. 28:356–361. 2015. View Article : Google Scholar : PubMed/NCBI
16	Lv B, Huang J, Yuan H, Yan W, Hu G and Wang J: Tumor necrosis factor-α as a diagnostic marker for neonatal sepsis: A meta-analysis. ScientificWorldJournal. 2014:4714632014. View Article : Google Scholar : PubMed/NCBI
17	DeLong WG Jr and Born CT: Cytokines in patients with polytrauma. Clin Orthop Relat Res. 1–65. 2004.PubMed/NCBI
18	Stover JF, Sakowitz OW, Schoning B, Rupprecht S, Kroppenstedt SN, Thomale UW, Woiciechowsky C and Unterberg AW: Norepinephrine infusion increases interleukin-6 in plasma and cerebrospinal fluid of brain-injured rats. Med Sci Monit. 9:Br382–Br388. 2003.PubMed/NCBI
19	Baeuerle PA and Henkel T: Function and activation of NF-kappa B in the immune system. Annu Rev Immunol. 12:141–179. 1994. View Article : Google Scholar : PubMed/NCBI
20	Tone M, Powell MJ, Tone Y, Thompson SA and Waldmann H: IL-10 gene expression is controlled by the transcription factors Sp1 and Sp3. J Immunol. 165:286–291. 2000. View Article : Google Scholar : PubMed/NCBI
21	Luo Q, Ma X, Wahl SM, Bieker JJ, Crossley M and Montaner LJ: Activation and repression of interleukin-12 p40 transcription by erythroid Kruppel-like factor in macrophages. J Biol Chem. 279:18451–18456. 2004. View Article : Google Scholar : PubMed/NCBI
22	Riedemann NC, Neff TA, Guo RF, Bernacki KD, Laudes IJ, Sarma JV, Lambris JD and Ward PA: Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression. J Immunol. 170:503–507. 2003. View Article : Google Scholar : PubMed/NCBI
23	Pritts T, Hungness E, Wang Q, Robb B, Hershko D and Hasselgren PO: Mucosal and enterocyte IL-6 production during sepsis and endotoxemia-role of transcription factors and regulation by the stress response. Am J Surg. 183:372–383. 2002. View Article : Google Scholar : PubMed/NCBI
24	Liz J and Esteller M: lncRNAs and microRNAs with a role in cancer development. Biochim Biophys Acta. 1859:169–176. 2016. View Article : Google Scholar : PubMed/NCBI
25	Varshney J and Subramanian S: MicroRNAs as potential target in human bone and soft tissue sarcoma therapeutics. Front Mol Biosci. 2:312015. View Article : Google Scholar : PubMed/NCBI
26	Witwer KW, Sisk JM, Gama L and Clements JE: MicroRNA regulation of IFN-beta protein expression: Rapid and sensitive modulation of the innate immune response. J Immunol. 184:2369–2376. 2010. View Article : Google Scholar : PubMed/NCBI
27	Jones MR, Quinton LJ, Blahna MT, Neilson JR, Fu S, Ivanov AR, Wolf DA and Mizgerd JP: Zcchc11-dependent uridylation of microRNA directs cytokine expression. Nat Cell Biol. 11:1157–1163. 2009. View Article : Google Scholar : PubMed/NCBI
28	Rogler CE, Levoci L, Ader T, Massimi A, Tchaikovskaya T, Norel R and Rogler LE: MicroRNA-23b cluster microRNAs regulate transforming growth factor-beta/bone morphogenetic protein signaling and liver stem cell differentiation by targeting Smads. Hepatology. 50:575–584. 2009. View Article : Google Scholar : PubMed/NCBI
29	Luzi E, Marini F, Sala SC, Tognarini I, Galli G and Brandi ML: Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor. J Bone Miner Res. 23:287–295. 2008. View Article : Google Scholar : PubMed/NCBI
30	Chen L, Zheng J, Zhang Y, Yang L, Wang J, Ni J, Cui D, Yu C and Cai Z: Tumor-specific expression of microRNA-26a suppresses human hepatocellular carcinoma growth via cyclin-dependent and -independent pathways. Mol Ther. 19:1521–1528. 2011. View Article : Google Scholar : PubMed/NCBI
31	Lu J, He ML, Wang L, Chen Y, Liu X, Dong Q, Chen YC, Peng Y, Yao KT, Kung HF and Li XP: MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2. Cancer Res. 71:225–233. 2011. View Article : Google Scholar : PubMed/NCBI
32	Zhang B, Liu XX, He JR, Zhou CX, Guo M, He M, Li MF, Chen GQ and Zhao Q: Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer. Carcinogenesis. 32:2–9. 2011. View Article : Google Scholar : PubMed/NCBI
33	Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P, Torbenson M, Clark KR, et al: Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell. 137:1005–1017. 2009. View Article : Google Scholar : PubMed/NCBI
34	Ciarapica R, Russo G, Verginelli F, Raimondi L, Donfrancesco A, Rota R and Giordano A: Deregulated expression of miR-26a and Ezh2 in rhabdomyosarcoma. Cell Cycle. 8:172–175. 2009. View Article : Google Scholar : PubMed/NCBI
35	Yang X, Liang L, Zhang XF, Jia HL, Qin Y, Zhu XC, Gao XM, Qiao P, Zheng Y, Sheng YY, et al: MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway. Hepatology. 58:158–170. 2013. View Article : Google Scholar : PubMed/NCBI